We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

DPC Acquires Rights to Sperm Analyzer

By HospiMedica staff writers
Posted on 05 Apr 2002
Exclusive distribution rights to a sperm analyzing system have been acquired by Diagnostic Products Corp. (DPC, Los Angeles, CA, USA; www.dpcweb.com) from Medical Electronic Systems Ltd. (MES, Caesarea, Israel).

The analyzer, called SQA-V, is a low-cost system that utilizes electro-optics, computer algorithms, and video microscopy to provide rapid and reliable semen analysis in less than 75 seconds. The system can automatically adapt to accommodate fresh, frozen, and treated semen, and provides on-screen visualization, image freezing, Kruger and World Health Organization (WHO) criteria, and built-in archiving capabilities. The self-diagnostic quality controls ensure repeatable results, regardless of semen preparation or technician, says MES.

"We see the addition of the MES sperm analyzer as a strategic complement to our Immulite business in the fertility markets,” said Ira Ziering, vice president, international, DPC. "We are now able to offer the reproductive testing market the highest quality products relating to both male and female fertility.”




Related Links:
DPC

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Phototherapy Eye Protector
EyeMax2
New
Transducer Covers
Surgi Intraoperative Covers

Latest Business News

Boston Scientific Acquires Medical Device Company Intera Oncology

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024